Gilead Sciences Inc
GILD·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$130.66
Today
-1.9%
YTD
+9.6%
About
Gilead Sciences, Inc. is a biopharmaceutical company that focuses on the research, development, and marketing of therapies targeting unmet medical needs and life-threatening conditions. Founded in 1987, the company is headquartered in Foster City, California, and operates in the United States, Europe, and internationally. It trades under the ticker GILD on the NASDAQ. Buy GILD stock to receive updates and information on the GILD price chart.
Price chart
Closing price history for GILD (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)17.67
P/S (TTM)5.47
P/B (TTM)6.86
Market cap$161.19B
Cap tierLarge-cap
Industry avg P/E-17.25
Profitability
Gross margin79.41%
EBIT margin40.41%
Net margin28.94%
ROE43.19%
ROA16.35%
Earnings & Revenue
Revenue (TTM)$29.79B
Revenue growth (1Y)+3.8%
EPS (TTM)$7.35
Free cash flow$10.23B
Total debt$22.17B
Dividends & Risk
Dividend rate$3.22
Dividend yield2.48%
Ex-date13 Mar '26
Beta (5Y)0.36
Employees17,000
Next earnings6 Aug '26
Trade history
Closed trades
1
Realized return
+0.5%
| Opened | Closed | P/L% | Open / Target / Close | |
|---|---|---|---|---|
| 19 Mar '20 | 0d | 19 Mar '20 | +0.45% | $81.79→$899.69→$82.16 |